Clinical data from a systematic review and meta-analysis showed a trend toward reduced PJI risk with silver-coated endoprostheses in both primary oncologic reconstruction and revision cases, though neither result reached statistical significance [ 79 ].
← all excerpts
Translational Progress and Clinical Challenges in Bioengineered Bone and Joint Repair
1
—
—